Oak Hill Bio

Oak Hill Bio

HealthUnited States

Oak Hill Bio is a therapeutics company focused on developing treatments for rare diseases. They have secured funding to advance rugonersen, an experimental treatment for Angelman syndrome, into late-stage clinical testing, highlighting their commitment to addressing unmet medical needs in this community.

$32.5MVisit website ↗

Funding history

  1. $32.5M2026-06-08
    Source: news.google.com ↗

Founder

Josh Distler
Josh Distler
CEO

More Health companies

Recently funded startups in the same category.

Related on Datapile

Oak Hill Bio — Health startup in United States | Datapile